LI XiaoDong-Doctors-英文

Expertise

Specialized in functional, metabolic, and molecular imaging diagnosis, including PET/CT and SPECT/CT for early detection of malignant tumors, differentiation of benign and malignant lesions, staging and restaging, treatment response assessment, and recurrence surveillance, as well as image-guided biopsy localization and precise radiotherapy target delineation. Proficient in myocardial perfusion and metabolic imaging for evaluation of myocardial ischemia and viability, cerebral perfusion and metabolic imaging for the diagnosis of cerebrovascular and neurodegenerative disorders, renal dynamic imaging for assessment of renal function such as GFR, and whole-body bone scintigraphy for early detection of bone metastases and differential diagnosis of thyroid and other endocrine disorders. Specialized in targeted radionuclide therapy, including individualized iodine-131 treatment for refractory hyperthyroidism; postoperative iodine-131 remnant ablation, adjuvant therapy, and treatment of metastatic lesions in differentiated thyroid cancer; radionuclide therapy for severe bone pain caused by multiple skeletal metastases from malignant tumors (such as strontium-89 chloride and radium-223 dichloride); radioactive seed implantation for local control of solid malignant tumors; lutetium-177 receptor-targeted radionuclide therapy for neuroendocrine tumors; yttrium-90 microsphere radioembolization for malignant liver tumors; and other radionuclide-based therapies for refractory malignancies.